LEHNE'S PHARMACOTHERAPEUTICS
FOR ADVANCED PRACTICE NURSES AND PHYSICIAN ASSISTANTS 3RD EDITION
3RD EDITION
,CHAPTER 1: PRESCRIPTIVE AUTHORITY TEST BANK __________________________________ 5
CHAPTER 2: RATIONAL DRUG SELECTION AND PRESCRIPTION WRITING _________________ 9
CHAPTER 3: PROMOTING POSITIVE OUTCOMES OF DRUG THERAPY ___________________ 13
CHAPTER 4: PHARMACOKINETICS, PHARMACODYNAMICS, AND DRUG INTERACTIONS ___ 17
CHAPTER 5: ADVERSE DRUG REACTIONS AND MEDICATION ERRORS __________________ 26
CHAPTER 6: INDIVIDUAL VARIATION IN DRUG RESPONSES ___________________________ 34
CHAPTER 7 GENETIC AND GENOMIC CONSIDERATIONS IN PHARMACOTHERAPEUTICS ____ 40
CHAPTER 8: DRUG THERAPY DURING PREGNANCY AND BREAST-FEEDING ______________ 48
CHAPTER 9: DRUG THERAPY IN PEDIATRIC PATIENTS _______________________________ 54
CHAPTER 10: DRUG THERAPY IN GERIATRIC PATIENTS ______________________________ 61
CHAPTER 11: BASIC PRINCIPLES OF NEUROPHARMACOLOGY _________________________ 68
CHAPTER 12: PHYSIOLOGY OF THE PERIPHERAL NERVOUS SYSTEM ____________________ 73
CHAPTER 13: MUSCARINIC AGONISTS AND CHOLINESTERASE INHIBITORS ______________ 78
CHAPTER 14 MUSCARINIC ANTAGONISTS _________________________________________ 84
CHAPTER 15: ADRENERGIC AGONISTS ____________________________________________ 89
CHAPTER 16: ADRENERGIC ANTAGONISTS _________________________________________ 96
CHAPTER 17: INDIRECT-ACTING ANTIADRENERGIC AGENTS _________________________ 106
CHAPTER 18: INTRODUCTION TO CENTRAL NERVOUS SYSTEM PHARMACOLOGY _______ 112
CHAPTER 19: DRUGS FOR PARKINSON'S DISEASE __________________________________ 117
CHAPTER 20: DRUGS FOR ALZHEIMER'S DISEASE __________________________________ 123
CHAPTER 21: DRUGS FOR SEIZURE DISORDERS ____________________________________ 129
CHAPTER 22: DRUGS FOR MUSCLE SPASM AND SPASTICITY _________________________ 135
CHAPTER 23: LOCAL ANESTHETICS ______________________________________________ 141
CHAPTER 24: OPIOID ANALGESICS, OPIOID ANTAGONISTS, AND NONOPIOID CENTRALLY
ACTING ANALGESICS __________________________________________________________ 148
CHAPTER 25: DRUGS FOR HEADACHE ____________________________________________ 156
CHAPTER 26: ANTIPSYCHOTIC AGENTS AND THEIR USE IN SCHIZOPHRENIA ____________ 164
CHAPTER 27: ANTIDEPRESSANTS TEST BANK _____________________________________ 173
CHAPTER 28: DRUGS FOR BIPOLAR DISORDER ____________________________________ 180
CHAPTER 29: SEDATIVE-HYPNOTIC DRUGS _______________________________________ 187
CHAPTER 30: MANAGEMENT OF ANXIETY DISORDERS ______________________________ 192
CHAPTER 31: CENTRAL NERVOUS SYSTEM STIMULANTS AND ATTENTION-
DEFICIT/HYPERACTIVITY DISORDER _____________________________________________ 198
CHAPTER 32: SUBSTANCE USE DISORDERS I: BASIC CONSIDERATIONS ________________ 205
,CHAPTER 33: SUBSTANCE USE DISORDERS II: ALCOHOL _____________________________ 210
CHAPTER 34: SUBSTANCE USE DISORDERS III: NICOTINE AND SMOKING ______________ 217
CHAPTER 35: SUBSTANCE USE DISORDERS IV: MAJOR DRUGS OF ABUSE OTHER THAN
ALCOHOL AND NICOTINE ______________________________________________________ 223
CHAPTER 36: REVIEW OF HEMODYNAMICS _______________________________________ 234
CHAPTER 37: DIURETICS _______________________________________________________ 238
CHAPTER 38: DRUGS ACTING ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ____ 244
CHAPTER 39: CALCIUM CHANNEL BLOCKERS ______________________________________ 252
CHAPTER 40: VASODILATORS __________________________________________________ 256
CHAPTER 41: DRUGS FOR HYPERTENSION ________________________________________ 262
CHAPTER 42: DRUGS FOR HEART FAILURE ________________________________________ 273
CHAPTER 43: ANTIDYSRHYTHMIC DRUGS ________________________________________ 284
CHAPTER 44: PROPHYLAXIS OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: DRUGS THAT
HELP NORMALIZE CHOLESTEROL AND TRIGLYCERIDE LEVELS ________________________ 296
CHAPTER 45: DRUGS FOR ANGINA PECTORIS _____________________________________ 307
CHAPTER 46: ANTICOAGULANT, ANTIPLATELET, AND THROMBOLYTIC DRUGS _________ 317
CHAPTER 47: DRUGS FOR DEFICIENCY ANEMIAS __________________________________ 327
CHAPTER 48: DRUGS FOR DIABETES MELLITUS ____________________________________ 336
CHAPTER 49: DRUGS FOR THYROID DISORDERS ___________________________________ 345
CHAPTER 50: ESTROGENS AND PROGESTINS: BASIC PHARMACOLOGY AND
NONCONTRACEPTIVE APPLICATIONS ____________________________________________ 354
CHAPTER 51: BIRTH CONTROL __________________________________________________ 358
CHAPTER 52: ANDROGENS _____________________________________________________ 368
CHAPTER 53: DRUGS FOR ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA
___________________________________________________________________________ 374
CHAPTER 54. DRUGS FOR SEXUAL DYSFUNCTION __________________________________ 378
CHAPTER 55. DRUGS FOR TRANSGENDER HEALTH _________________________________ 384
CHAPTER 56: REVIEW OF THE IMMUNE SYSTEM ___________________________________ 402
CHAPTER 57: CHILDHOOD IMMUNIZATION _______________________________________ 408
CHAPTER 58: ANTIHISTAMINES _________________________________________________ 416
CHAPTER 59: CYCLOOXYGENASE INHIBITORS: NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
AND ACETAMINOPHEN ________________________________________________________ 424
CHAPTER 60: GLUCOCORTICOIDS IN NONENDOCRINE DISORDERS ____________________ 432
CHAPTER 61: DRUG THERAPY OF RHEUMATOID ARTHRITIS _________________________ 441
CHAPTER 62: DRUG THERAPY OF GOUT __________________________________________ 446
, CHAPTER 63: DRUGS AFFECTING CALCIUM LEVELS AND BONE MINERALIZATION _______ 451
CHAPTER 64: DRUGS FOR ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE _ 460
CHAPTER 65: DRUGS FOR ALLERGIC RHINITIS, COUGH, AND COLDS __________________ 471
CHAPTER 66: DRUGS FOR PEPTIC ULCER DISEASE __________________________________ 479
CHAPTER 67: LAXATIVES ______________________________________________________ 486
CHAPTER 68: OTHER GASTROINTESTINAL DRUGS __________________________________ 495
CHAPTER 69: VITAMINS _______________________________________________________ 506
CHAPTER 70: DRUGS FOR WEIGHT LOSS _________________________________________ 513
CHAPTER 71: COMPLEMENTARY AND ALTERNATIVE THERAPIES _____________________ 520
CHAPTER 72: BASIC PRINCIPLES OF ANTIMICROBIAL THERAPY _______________________ 525
CHAPTER 73: DRUGS THAT WEAKEN THE BACTERIAL CELL WALL I: PENICILLIN’S ________ 532
CHAPTER 74: DRUGS THAT WEAKEN THE BACTERIAL CELL WALL II: OTHER DRUGS ______ 539
CHAPTER 75: BACTERIOSTATIC INHIBITORS OF PROTEIN SYNTHESIS __________________ 546
CHAPTER 76: AMINOGLYCOSIDES: BACTERICIDAL INHIBITORS OF PROTEIN SYNTHESIS __ 557
CHAPTER 77: SULFONAMIDES AND TRIMETHOPRIM _______________________________ 567
CHAPTER 78: DRUG THERAPY OF URINARY TRACT INFECTIONS ______________________ 574
CHAPTER 79: DRUGS THERAPY FOR TUBERCULOSIS ________________________________ 582
CHAPTER 80: MISCELLANEOUS ANTIBACTERIAL DRUGS _____________________________ 592
CHAPTER 81: ANTIFUNGAL AGENTS _____________________________________________ 597
CHAPTER 82: ANTIVIRAL AGENTS I: DRUGS FOR NON-HIV VIRAL INFECTIONS __________ 609
CHAPTER 83: ANTIVIRAL AGENTS II: DRUGS FOR HIV INFECTION AND RELATED
OPPORTUNISTIC INFECTIONS ___________________________________________________ 618
CHAPTER 84: DRUG THERAPY OF SEXUALLY TRANSMITTED DISEASES _________________ 625
CHAPTER 85: ANTHELMINTICS, ANTIPROTOZOAL DRUGS, AND ECTOPARASITICIDES ____ 631
CHAPTER 86 INTRODUCTION TO IMMUNOMODULATORS ___________________________ 635
CHAPTER 87: ANTICANCER DRUGS FOR THE NONSPECIALIST ________________________ 641
CHAPTER 88: PAIN MANAGEMENT IN PATIENTS WITH CANCER ______________________ 650
CHAPTER 89: DRUGS FOR THE EYE ______________________________________________ 660
CHAPTER 90: DRUGS FOR THE SKIN _____________________________________________ 667
CHAPTER 91: DRUGS FOR THE EAR ______________________________________________ 679
CHAPTER 92: AGENTS AFFECTING THE VOLUME AND ION CONTENT OF BODY FLUIDS ___ 686
CHAPTER 93: MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION ___________ 692
CHAPTER 94: ADDITIONAL ACUTE CARE DRUGS ___________________________________ 699